Karl Swedberg
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Blood Pressure and Hypertension Studies
- Heart rate and cardiovascular health
- Endocrinology, Diabetes and Metabolism top 0.05%
- Hormonal Regulation and Hypertension
Papers in
-
- Heart Failure Treatment and Management 257
- Cardiovascular Function and Risk Factors 58
- Heart rate and cardiovascular health 52
- Cardiac pacing and defibrillation studies 44
- Cardiac electrophysiology and arrhythmias 41
- Atrial Fibrillation Management and Outcomes 20
-
- Potassium and Related Disorders 18
- Co-authors
- John J.V. McMurray (208 shared papers)John Kjekshus (10 shared papers)Marc A. Pfeffer (75 shared papers)Salim Yusuf (62 shared papers)Eric L. Michelson (42 shared papers)Christopher B. Granger (55 shared papers)Scott D. Solomon (136 shared papers)Jan Östergren (25 shared papers)
- Journals
- European Journal of Heart Failure (114 papers)European Heart Journal (49 papers)Journal of the American College of Cardiology (45 papers)Circulation (27 papers)The American Journal of Cardiology (24 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Karl Swedberg
497 papers receiving 62.2k citations
Karl Swedberg's Hit Papers
Peers
Comparison fields: 5 of 185
- Cardiology and Cardiovascular Medicine 43.8k
- Endocrinology, Diabetes and Metabolism 7.8k
- Family Practice 622
- Nephrology 1.4k
- Geriatrics and Gerontology 646
Countries citing papers authored by Karl Swedberg
This map shows the geographic impact of Karl Swedberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Swedberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Swedberg more than expected).
Fields of papers citing papers by Karl Swedberg
This network shows the impact of papers produced by Karl Swedberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Swedberg. The network helps show where Karl Swedberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Swedberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 509 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure Hit paper breakdown → | 2014 | 4433 |
| 2 | Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) Hit paper breakdown → | 1988 | 2973 |
| 3 | Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms Hit paper breakdown → | 2010 | 2075 |
| 4 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2056 |
| 5 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 1796 |
| 6 | Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Hit paper breakdown → | 2010 | 1736 |
| 7 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Hit paper breakdown → | 2003 | 1680 |
| 8 | Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) Hit paper breakdown → | 2005 | 1667 |
| 9 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1340 |
| 10 | Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Hit paper breakdown → | 2003 | 1276 |
| 11 | Person-Centered Care — Ready for Prime Time Hit paper breakdown → | 2011 | 1201 |
| 12 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1121 |
| 13 | Targeted Anticytokine Therapy in Patients With Chronic Heart Failure Hit paper breakdown → | 2004 | 964 |
| 14 | Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Hit paper breakdown → | 1990 | 906 |
| 15 | Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Hit paper breakdown → | 1993 | 905 |
| 16 | Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies Hit paper breakdown → | 2012 | 866 |
| 17 | Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Hit paper breakdown → | 2010 | 831 |
| 18 | CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL Hit paper breakdown → | 2003 | 795 |
| 19 | EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION Hit paper breakdown → | 1981 | 784 |
| 20 | Predictors of mortality and morbidity in patients with chronic heart failure Hit paper breakdown → | 2005 | 762 |
About Karl Swedberg
Karl Swedberg is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Hematology, having authored 509 papers that have together received 64.7k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (257 papers), Cardiovascular Function and Risk Factors (58 papers), Heart rate and cardiovascular health (52 papers), Cardiac pacing and defibrillation studies (44 papers), Cardiac electrophysiology and arrhythmias (41 papers), Hormonal Regulation and Hypertension (23 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Potassium and Related Disorders (18 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (43.8k citations), Endocrinology, Diabetes and Metabolism (7.8k citations), Family Practice (622 citations), Nephrology (1.4k citations) and Geriatrics and Gerontology (646 citations). Karl Swedberg has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include John J.V. McMurray, John Kjekshus, Marc A. Pfeffer, Salim Yusuf, Eric L. Michelson, Christopher B. Granger, Scott D. Solomon, Jan Östergren, Bertil Olofsson and Jean L. Rouleau. Their work appears in journals such as European Journal of Heart Failure, European Heart Journal, Journal of the American College of Cardiology, Circulation and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.